Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Alpha-Methylacyl Coenzyme A Racemase Measurement	NCIT_C132364	[The determination of the amount of alpha-methylacyl coenzyme A racemase in a biological sample.]
Kininogen Family Gene	NCIT_C20730	[Encoding Kininogen proteins, Kininogen Family Genes belong to the Cystatin Superfamily, a single evolutionary superfamily of three inhibitory subfamilies that encode proteins with likely protective function and structural similarities that include cystatin-like sequences: Stefins (Type 1 Cystatins), Cystatins (Type 2 Cystatins), and Kininogens. Many members are active cysteine protease inhibitors; others have lost or never acquired inhibitory activity. Kininogens contain 3 cystatin-like domains, each with 2 disulfide bonds. Type 2 Cystatins contain multiple cystatin-like domains and have 2 intrachain disulfide bonds. Type 1 Cystatins contain multiple cystatin-like domains and lack disulfide bridges. (NCI)]
Alpha-Methylacyl Coenzyme A Racemase mRNA Measurement	NCIT_C132365	[The determination of the amount of alpha-methylacyl coenzyme A racemase mRNA in a biological sample.]
Squamous Epithelial Cells to Total Cells Ratio Measurement	NCIT_C132366	[The determination of the ratio of the squamous epithelial cells compared to the total cells present in a sample. The measurement may be expressed as a ratio or percentage.]
Study Purpose	NCIT_C146997	[The overall rationale, reason, or intention of the clinical study.]
Protoporphyrin Measurement	NCIT_C146998	[The determination of the amount of protoporphyrin present in a sample.]
Mode of Action	NCIT_C146999	[The mechanism by which a pharmacologically active substance produces an effect on the cellular level of a living organism or in a biochemical system.]
Recurrent Central Nervous System Non-Hodgkin Lymphoma	NCIT_C146990	[The reemergence of central nervous system non-Hodgkin lymphoma after a period of remission.]
Recurrent Non-Hodgkin Lymphoma	NCIT_C9251	[The reemergence of non-Hodgkin lymphoma after a period of remission.]
Recurrent Central Nervous System Lymphoma	NCIT_C138019	[The reemergence of central nervous system lymphoma after a period of remission.]
Fluorine-19 Magnetic Resonance Imaging	NCIT_C146991	[Magnetic resonance imaging that uses a probe labeled with 19F. MR sensitivity of 19F is relatively high and no fluorine atoms exist in biological tissues, resulting in low endogenous background noise.]
Allogeneic Umbilical Cord Blood-derived HSPCs NLA101	NCIT_C146992	[A preparation of universal, off-the-shelf, ex vivo expanded, allogeneic umbilical cord blood (UCB)-derived hematopoietic stem and progenitor cells (HSPCs) that can potentially be used to improve hematopoietic recovery after chemotherapy or hematopoietic cell transplantation (HCT). Upon administration of allogeneic HSPCs NLA101, these cells increase and restore the number of HSPCs, which may prevent or decrease infection and other complications of chemotherapy-induced neutropenia (CIN) or cord blood transplantation.]
Adoptive Cell Therapy Agent	NCIT_C142078	[A preparation of allogeneic or autologous cells that is meant to be administered to a patient and may have a therapeutic effect.]
Observed Medical Device Type In Intended Location	NCIT_C146994	[A description of the type of medical device that is found in a subject and is present in its intended location within the body.]
Adaptive Study Design Indicator	NCIT_C146995	[A study design which includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and/or hypotheses based on analysis of data, usually interim data.]
Supplemental Qualifiers Tabulation Dataset	NCIT_C146996	[A dataset containing supplemental information, specifically non-standard variables, to parent records in a domain.]
Tabulation Dataset	NCIT_C142727	[Standardized clinical trial information arranged in a table.]
MD Anderson Symptom Inventory - Core	NCIT_C107378	[A self-administered questionnaire designed to assess multiple symptoms experienced by cancer patients and the interference with daily living caused by these symptoms.]
OTC Monograph Drug Product Manufactured Under Contract	NCIT_C132334	[A marketing category specifying that an OTC monograph drug product is manufactured by a contract manufacturer and not marketed by the contract manufacturer.]
Structured Product Labeling Marketing Category	NCIT_C73581	[A characteristic specifying a category for marketing a medicinal product.]